Lind Global Fund III LP

13F Holdings History for Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Symbol: SLXN on Nasdaq
Investment type: Equity / Ordinary shares, par value $0.0135 per share
Latest Disclosed Ownership: 224K shares
Security Ownership: 9.9%

Lind Global Fund III LP ownership in Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

2025-09-18 - Lind Global Fund III LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 224K shares of Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN). This represents 9.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Lind Global Fund III LP	9.9%		$197K	224K			$0.88	13G	9/12/2025	18 Sep 2025 17:47:12